Frequently Asked Questions (FAQs) for the Division of Chemistry: Disciplinary Research Programs (CHE-DRP) NSF 19-577
Available Formats: HTML: https://www.nsf.gov/pubs/2019/nsf19074/nsf19074.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2019/nsf19074/nsf19074.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf19074Public Comment: These Frequently Asked Questions (FAQs) are related to Program Solicitation NSF 19-577, Atmospheric and Geospace Sciences Postdoctoral Research Fellowships (AGS-PRF).This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - June 18, 2019 Category: Science Source Type: funding

Postdoctoral Research Associate Training (PRAT) Program (Fi2)
Funding Opportunity PAR-19-286 from the NIH Guide for Grants and Contracts. The NIGMS Postdoctoral Research Associate Training (PRAT) Programs overarching goal is to provide high quality postdoctoral research training in the basic biomedical sciences to a diverse group of postdoctoral fellows in NIH Intramural research laboratories, and to prepare them for leadership positions in biomedical careers. Research projects proposed should focus on areas within the NIGMS mission, which include but are not limited to biological chemistry, biophysics, bioinformatics, cellular and molecular biology, computational biosciences, devel...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 21, 2019 Category: Research Source Type: funding

Next Generation Networks for Neuroscience (NeuroNex)
Preliminary Proposal Deadline Date: June 14, 2019 Program Guidelines: NSF 19-563Understanding how behavior emerges from the dynamic patterns of electrical and chemical activity of brain circuits is universally recognized as one of the great, unsolved mysteries of science. Advances in recent decades have elucidated how individual elements of the nervous system and brain relate to specific behaviors and cognitive processes. However, there remains much to discover to attain a comprehensive understanding of how the healthy brain functions, specifically, the general ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=50...
Source: NSF Upcoming Due Dates - May 15, 2019 Category: Science Source Type: funding

Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-261 from the NIH Guide for Grants and Contracts. The NICHD has a state-of-the-art Chemical Synthesis and Optimization Facility for advancing male and/or female non-hormonal contraception developmentwith the capabilities and capacity for preclinical services including Investigational Device Exemption (IDE) or Investigational New Drug (IND)-enabling studies (e.g., protein generation, high throughput screening, structure activity relationships, hit-to-lead generation, drug metabolism, fertility studies). The purpose of this FOA is to provide investigators with a mechanism to request services from t...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2019 Category: Research Source Type: funding

Division of Chemistry: Disciplinary Research Programs (CHE-DRP)
Available Formats: HTML: https://www.nsf.gov/pubs/2019/nsf19577/nsf19577.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2019/nsf19577/nsf19577.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf19577This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - April 16, 2019 Category: Science Source Type: funding

Centers for Chemical Innovation (CCI)
Available Formats: HTML: https://www.nsf.gov/pubs/2019/nsf19576/nsf19576.htm?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2019/nsf19576/nsf19576.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf19576This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - April 16, 2019 Category: Science Source Type: funding

Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed)
Funding Opportunity RFA-FD-19-018 from the NIH Guide for Grants and Contracts. The intended outcome of this cooperative agreement is to advance the goal of a national food safety system by supporting and enhancing state food laboratories tasked with investigation of foodborne disease outbreaks in activities including: 1. Ensuring microbiological and chemical food analyses performed on behalf of the State manufactured food regulatory programs are conducted within the scope of an International Organization for Standardization (ISO)/ International Electrotechnical Commission (IEC) 17025 accredited laboratory; 2. Strengthenin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 19, 2019 Category: Research Source Type: funding

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)
Funding Opportunity PA-19-201 from the NIH Guide for Grants and Contracts. The purpose of this FOAs are to encourage mechanistic research to investigate the impact of sleep disturbances on chronic pain. The mechanisms and processes underlying the contribution of sleep disturbances to chronic pain development and maintenance may be very broad. This FOA encourages interdisciplinary collaborations by experts from multiple fieldsneuroscientists, psychologists,endocrinologists, immunologists, geneticists, pharmacologists, chemists, physicists, behavioral scientists, clinicians, caregivers, and others in relevant fields of inqu...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 28, 2019 Category: Research Source Type: funding

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)
Funding Opportunity PA-19-200 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to encourage mechanistic research to investigate the impact of sleep disturbances on pain. The mechanisms and processes underlying the contribution of sleep and sleep disturbances to pain perception and the development and maintenance of chronic pain may be very broad. This FOA encourages interdisciplinary research collaborations by experts from multiple fieldsneuroscientists, psychologists, endocrinologists, immunologists, geneticists, pharmacologists, chemists, physicists, behavioral scientists, clinicians, caregivers, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 28, 2019 Category: Research Source Type: funding

Welcome the New Director for the NIH Center for Scientific Review – Dr. Noni Byrnes
It gives me enormous pleasure to extend my warm congratulations to a friend and colleague, Noni H. Byrnes, Ph.D., for her recent selection as the new Director for the NIH Center for Scientific Review (CSR).    CSR serves a vital role. Not only does CSR manage the receipt and referral of all grant applications for NIH and for other parts of the U.S. Department of Health and Human Services, dedicated CSR staff also oversee the peer review of approximately 75 percent of the more than 80,000 grant applications NIH receives each year. One can find more data on NIH peer review “in” the NIH Data Book.&nbs...
Source: NIH Extramural Nexus - February 21, 2019 Category: Research Authors: Mike Lauer Tags: Open Mike CSR Peer review Source Type: funding

NSF/CASIS Collaboration on Transport Phenomena Research on the International Space Station (ISS) to Benefit Life on Earth
Full Proposal Window: March 15, 2019 Program Guidelines: NSF 19-525The Division of Chemical, Bioengineering and Environmental Transport (CBET) in the Engineering Directorate of the National Science Foundation (NSF) is partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general field of fluid ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505258&WT.mc_id=USNSF_39&WT.mc_ev=clickThis is an NSF Upcoming Due Dates item. (Source: NSF Upcoming Due Dates)
Source: NSF Upcoming Due Dates - February 13, 2019 Category: Science Source Type: funding

Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-19-001 from the NIH Guide for Grants and Contracts. Chemical modifications of protein, DNA and RNA nucleoside moieties play critical roles in regulating gene expression. Emerging evidence suggests RNA modifications have substantive roles in multiple basic biological processes. Epitranscriptomics can be defined as the aggregate suite of functional biochemical modifications to the transcriptome within a cell. Recent studies in yeast, Drosophila, rodent and human models demonstrate that stressors can induce RNA modifications, with specific reprogramming of some regulatory RNAs. The NIEHS seeks to s...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2019 Category: Research Source Type: funding

Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-19-002 from the NIH Guide for Grants and Contracts. Chemical modifications of proteins, DNA and RNA nucleoside moieties play critical roles in regulating gene expression. Emerging evidence suggests these RNA modifications (epitranscriptomics) have substantive roles in basic biological processes. Recent studies in yeast, Drosophila and rodent models demonstrate stressors can induce RNA modifications, with specific epitranscriptomic reprogramming of some regulatory RNAs. The purpose of the eFRAMED FOA is to solicit and support R21 applications that propose conducting innovative, high risk, high re...
Source: NIH Funding Opportunities (Notices, PA, RFA) - February 8, 2019 Category: Research Source Type: funding

Dear Colleague Letter: Division of Chemistry (CHE) International Supplements 2019
Available Formats: HTML: https://www.nsf.gov/pubs/2019/nsf19037/nsf19037.jsp?WT.mc_id=USNSF_25&WT.mc_ev=clickPDF: https://www.nsf.gov/pubs/2019/nsf19037/nsf19037.pdf?WT.mc_id=USNSF_25&WT.mc_ev=clickDocument Number: nsf19037This is an NSF Program Announcements and Information item. (Source: NSF Program Announcements and Information)
Source: NSF Program Announcements and Information - February 8, 2019 Category: Science Source Type: funding

NSF/CASIS Collaboration on Tissue Engineering and Mechanobiology on the International Space Station (ISS) to Benefit Life on Earth
Full Proposal Window: February 15, 2019 Program Guidelines: NSF 19-509The Divisions of Chemical, Bioengineering and Environmental Transport (CBET) and Civil, Mechanical, and Manufacturing Infrastructure (CMMI) in the Engineering Directorate of the National Science Foundation (NSF) are partnering with The Center for the Advancement of Science in Space (CASIS) to solicit research projects in the general fields of tissue engineering and mechanobiology that can utilize the International Space Station (ISS) National Lab to conduct research that will benefit life on ...More at https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=505...
Source: NSF Upcoming Due Dates - January 26, 2019 Category: Science Source Type: funding

Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)
Funding Opportunity RFA-AT-19-003 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications to establish a National Center for Natural Product Technology Methodology and Performance Optimization (NP-TEMPO). This initiative is to improve upon and strengthen technologies and methods used in natural products research. The NP-TEMPO, supported through the U41 cooperative agreement funding mechanism, is expected to overcome existing research limitations by developing and/or adapting cutting edge, innovative approaches and technologies that will have signif...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 22, 2019 Category: Research Source Type: funding

Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-AT-19-002 from the NIH Guide for Grants and Contracts. The National Center for Complementary and Integrative Health (NCCIH) with the Office of Dietary Supplements (ODS) solicit applications for the development of an NMR Open Data Exchange (NP-NODE) and associated efforts to accelerate coordination and data sharing among natural products researchers more broadly. The NP-NODE will create the resources necessary to facilitate the capacity to upload, download, store, search and analyze raw NMR data. This resource will comply with the principle that scientific data should be Findable, Accessible, Intero...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 22, 2019 Category: Research Source Type: funding

Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-146 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) intends to support investigators who have interest and capability in the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIH wishes to stimulate research in 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics, 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest, 3) Later stage lead optimization to improve efficacy and pharmacokinetics, and 4) Initial dr...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2019 Category: Research Source Type: funding

Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
Funding Opportunity PAR-19-147 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis w...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 8, 2019 Category: Research Source Type: funding

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)
Funding Opportunity RFA-AT-19-009 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 3, 2019 Category: Research Source Type: funding

Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)
Funding Opportunity RFA-AT-19-008 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Center for Complementary and Integrative Health (NCCIH) solicits grant research applications to study minor cannabinoids and terpenes in the cannabis plant as it relates to pain and nociception. Minor cannabinoids are defined as any and all cannabinoids from the cannabis plant other than ?9-tetrahydrocannabinol (?9-THC). Cannabinoids and terpenes of particular interest include the following: Cannabidiol (CBD), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC), Myrcene, ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 3, 2019 Category: Research Source Type: funding

Resources for Technology Dissemination (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-EB-18-002 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support non-commercial lab-to-user dissemination of novel, reliable imaging and bioengineering technologies, including devices, software, methods, chemical agents, etc. Proposed technologies should have been prototyped, validated, and are potentially highly impactful to the research community. However, their beyond-the-lab dissemination via commercialization or industry partnership is not anticipated. Projects should focus on transforming functioning prototypes to usable tools and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 26, 2018 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)
Funding Opportunity PA-19-124 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2018 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)
Funding Opportunity PA-19-125 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2018 Category: Research Source Type: funding

NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-EY-19-001 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for short-term, proof-of-principle research projects that will provide preliminary data for a future FOA aimed at the development of new models that emulate human visual system anatomy, physiology and disease processes. The model system might involve specific defects generated by transgenic gene insertion and/or deletion, gene editing, chemical/physical means, and/or other approaches to emulate characteristics of human disease or create defects amenable to cell...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 20, 2018 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Fu...
Source: NIDDK Funding Opportunities - December 20, 2018 Category: Endocrinology Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Fu...
Source: NIDDK Funding Opportunities - December 20, 2018 Category: Endocrinology Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Not Allowed)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Fu...
Source: NIDDK Funding Opportunities - December 20, 2018 Category: Endocrinology Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Clinical Trial Required)
The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering backgrounds to integrate their expertise with NIH-relevant research. This Fu...
Source: NIDDK Funding Opportunities - December 20, 2018 Category: Endocrinology Source Type: funding

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites U01 cooperative agreement applications for Physical Science-Oncology Projects (PS-OP). The goal of the PS-OPs is to foster the convergence of physical sciences approaches and perspectives with cancer research to advance our understanding of cancer biology and oncology by forming small transdisciplinary teams of physical scientists and cancer biologists/physician-scientists. Examples of physical scientists may include engineers, physicists, mathematicians, chemists, and computer scientists. The PS...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 12, 2018 Category: Research Source Type: funding

Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional)
Funding Opportunity RFA-NS-19-014 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports the development of PET radioligands that identify proteinopathies or pathological processes associated with the human biology of Alzheimer's disease related dementias (ADRDs). Activities supported under this FOA include, but are not limited to the in vitro screening of existing ligands against human ADRD brain tissue, medicinal chemistry support for development of new compounds and improvement of existing ligand specificity and selectivity, initial screening of ligands in appropriate animal m...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 11, 2018 Category: Research Source Type: funding

Mentored Quantitative Research Development Award (Parent K25 - Independent Basic Experimental Studies with Humans Required)
Funding Opportunity PA-19-089 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has thus far not been focused primarily on questions of health and disease. The K25 award will provide support and "protected time" for a period of supervised study and research for productive professionals with quantitative (e.g., mathematics, statistics, economics, computer science, imaging science, informatics, physics, chemistry) and engineering ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 28, 2018 Category: Research Source Type: funding

Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed)
Funding Opportunity PA-19-075 from the NIH Guide for Grants and Contracts. Purpose This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and cl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding

Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed)
Funding Opportunity PA-19-076 from the NIH Guide for Grants and Contracts. Purpose This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and cl...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 26, 2018 Category: Research Source Type: funding

CNH2: Dynamics of Integrated Socio-Environmental Systems (CNH2)
Letter of Intent Deadline Date: December 17, 2018 Program Guidelines: NSF 19-528The CNH2 Program supports research projects that advance basic scientific understanding of integrated socio-environmental systems and the complex interactions (dynamics, processes, and feedbacks) within and among the environmental (biological, physical and chemical) and human ("socio") (economic, social, political, or behavioral) components of such a system.  The program seeks proposals that emphasize the truly integrated nature of a socio-environmental system versus two discrete ...More at https://www.nsf.gov/funding/pgm_summ.js...
Source: NSF Upcoming Due Dates - November 17, 2018 Category: Science Source Type: funding

Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-19-008 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of pat...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DE-19-009 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications that propose transformative engineering solutions to technical challenges associated with new development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices for clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clini...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 15, 2018 Category: Research Source Type: funding

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-19-039 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally relea...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2018 Category: Research Source Type: funding

Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
Funding Opportunity PAR-19-040 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the optimization of small molecule or biologic compounds that are excellent candidates for therapeutic development. The mission of the CounterACT Program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released fro...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2018 Category: Research Source Type: funding

Division of Chemistry: Disciplinary Research Programs (CHE-DRP)
Full Proposal Window: October 1, 2018 All proposals to: Chemical Catalysis (CAT); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure, Dynamics and Mechanisms-B (CSDM-B); Chemical Theory, Models and Computational Methods (CTMC); and Chemical Synthesis (SYN) Program Guidelines: NSF 18-561This solicitation applies to nine CHE Disciplinary Chemistry Research Programs: Chemical Catalysis (CAT); Chemical Measurement and Imaging (CMI); Chemical Structure, Dynamics and Mechanisms-A (CSDM-A); Chemical Structure Dynamics and Mechanisms-B (CSDM-B); Chemical Synthesis( SYN); Chemical Theory, Models and Computat...
Source: NSF Upcoming Due Dates - September 1, 2018 Category: Science Source Type: funding

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)
Funding Opportunity PA-18-902 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is twofold: 1. to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and; 2. to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. This FOA calls for interdisciplinary collaborations across scientific disciplines engaged in microbiome and pro/prebiotic research including, but not limited to...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 14, 2018 Category: Research Source Type: funding

BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
Funding Opportunity RFA-MH-19-135 from the NIH Guide for Grants and Contracts. The purpose of this Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative is to encourage applications that will develop and validate novel tools to facilitate the detailed analysis and manipulation of complex circuits and provide insights into cellular interactions that underlie brain function. Critical advances in the treatment of brain disorders in human populations are hindered by our lack of ability to monitor and manipulate circuitry in safe, minimally-invasive ways. Clinical intervention with novel cell and cir...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 3, 2018 Category: Research Source Type: funding

Chemistry Research Experiences for Undergraduates (REU)
Full Proposal Deadline Date: August 22, 2018 Fourth Wednesday in August, Annually Thereafter Program Guidelines: PD 08-1986The Research Experiences for Undergraduates (REU) program supports active research participation by undergraduate students in any of the areas of research funded by the National Science Foundation. The NSF Division of Chemistry funds about 12-16 REU Sites a year (depending on the availability of funds) as part of the NSF-wide REU activity.  Projects involve students in meaningful ways in ongoing research programs or in research projects specifically designed for the REU ...More at https://www.nsf....
Source: NSF Upcoming Due Dates - July 23, 2018 Category: Science Source Type: funding

Drug Transport Across the Blood-Testis and Blood-Epididymal Barriers (R61/R33 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-853 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support research to elucidate the chemical features of non-native molecules that cross the blood-testis and/or blood-epidydimal barriers. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2018 Category: Research Source Type: funding

Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Funding Opportunity RFA-ES-18-002 from the NIH Guide for Grants and Contracts. The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, co...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 3, 2018 Category: Research Source Type: funding

Rigorous Resources for Rigorous Research
Over two years ago, NIH rolled out a policy to enhance reproducibility of its supported research through rigor and transparency. Applicants and reviewers were required to devote more attention to four areas: the rigor of the prior research (scientific premise), the rigor of the proposed research (scientific rigor), consideration of biological variables including sex, and the authentication of key biological and/or chemical resources. When the 21st Century Cures Act was passed later that same year, we were required, amongst other things, to assemble a working group of the Advisory Council to the NIH Director (ACD). These ex...
Source: NIH Extramural Nexus - July 2, 2018 Category: Research Authors: Mike Lauer and Patricia Valdez Tags: blog Open Mike ACD New Resources rigor Source Type: funding

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-830 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding

The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
Funding Opportunity PAR-18-831 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage applications from the scientific community to support outstanding research in the area of epitranscriptomics, i.e., the chemical modifications of RNA. Evidence is accumulating that RNA modifications regulate the function of both coding and noncoding RNAs, suggesting that these modifications are involved in both development, and in health and disease. Yet the extent and types of these RNA modifications as well as their roles in particular biological processes remain either p...
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding

Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).
Notice NOT-NS-18-072 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 14, 2018 Category: Research Source Type: funding

Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
Notice NOT-NS-18-071 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - June 12, 2018 Category: Research Source Type: funding